We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Appeals China's Decision To Overturn Viagra Patent

Law360 (September 27, 2004, 12:00 AM EDT) -- Pfizer Inc. will file an official appeal Tuesday against a decision by China's State Intellectual Property Office to overturn the U.S. drug maker’s patent for erectile-dysfunction drug Viagra, the Wall Street Journal’s Asian edition reported.

The appeal comes ahead of an Oct. 5 deadline and is a key component of Pfizer's strategy for regaining its Viagra patent, the newspaper reported, citing Beijing-based Pfizer Pharmaceuticals Ltd.'s chairman and general manager, E. Allan Gabor.

In addition to a judicial appeal with the Bejiing First Intermediate People's Court, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.